Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β

BACKGROUND: Tumors are heterogeneous in nature, composed of different cell populations with various mutations and/or phenotypes. Using a single drug to encounter cancer progression is generally ineffective. To improve the treatment outcome, multiple drugs of distinctive mechanisms but complementary...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellat, Vanessa, Verchère, Alice, Ashe, Sally A., Law, Benedict
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364656/
https://www.ncbi.nlm.nih.gov/pubmed/32678032
http://dx.doi.org/10.1186/s12885-020-07134-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364656/
https://www.ncbi.nlm.nih.gov/pubmed/32678032
http://dx.doi.org/10.1186/s12885-020-07134-3

Ejemplares similares